SCHEMBL29636200

SCHEMBL29636200

COc1cccc(-c2cnc3[nH]c(=O)[nH]c3c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 2/20 0.65
GSK3A P49840 2/20 0.65
GSK3B P49841 2/20 0.65
CDK5 Q00535 2/20 0.65
PLK4 O00444 1/20 0.65
CHEK1 O14757 1/20 0.65
PRKD3 O94806 1/20 0.65
MAP4K4 O95819 1/20 0.65
LYN P07948 1/20 0.65
RET P07949 1/20 0.65
PIM1 P11309 1/20 0.65
FER P16591 1/20 0.65
CDK2 P24941 1/20 0.65
MARK3 P27448 1/20 0.65
FLT4 P35916 1/20 0.65
KDR P35968 1/20 0.65
FLT3 P36888 1/20 0.65
SYK P43405 1/20 0.65
BLK P51451 1/20 0.65
RPS6KA3 P51812 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29636054 0.88 PRKD3 (0.63) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL29636083 0.85 GSK3A (0.66) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL29636031 0.82 PRKD3 (0.70) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL6813270 0.81 PDE3B (0.49) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL6810391 0.80 MEN1 (0.51) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL5788217 0.80 ALDH1A1 (0.56) CHEK1PDE3BPDE3AALDH1A1LMNA
SCHEMBL29636116 0.79 GRIN1 (0.54) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL6818041 0.78 PDE3B (0.46) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL29636109 0.77 PRKD3 (0.56) CDK1GSK3AGSK3BCDK5PLK4
SCHEMBL30176750 0.76 PRKD3 (0.55) CDK1GSK3AGSK3BCDK5PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338341-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-11759455-B2 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2023-09-19 US disclosed
US-20230000833-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-01-05 US disclosed
CN-114989164-A Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-09-02 CN disclosed
CN-110062761-B Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-05-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230000833-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN2C CDK1 856/4885GSK3A 1154/4885GSK3B 872/4885
US-11759455-B2 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators GRIN2B, GRIN2A, GRIN2C CDK1 856/4885GSK3A 1154/4885GSK3B 872/4885
US-20230338341-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN2C CDK1 856/4885GSK3A 1154/4885GSK3B 872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.